Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.

Latini FR, Hemerly JP, Oler G, Riggins GJ, Cerutti JM.

Endocr Relat Cancer. 2008 Sep;15(3):787-99. doi: 10.1677/ERC-08-0079. Epub 2008 Jun 17.

2.

ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.

Latini FR, Hemerly JP, Freitas BC, Oler G, Riggins GJ, Cerutti JM.

BMC Cancer. 2011 Jan 11;11:11. doi: 10.1186/1471-2407-11-11.

3.

RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function.

Rahbari R, Kitano M, Zhang L, Bommareddi S, Kebebew E.

J Clin Endocrinol Metab. 2013 Mar;98(3):E446-54. doi: 10.1210/jc.2012-3180. Epub 2013 Feb 7.

4.

Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells.

Guo RS, Yu Y, Chen J, Chen YY, Shen N, Qiu M.

Chin Med J (Engl). 2016 Jun 20;129(12):1439-46. doi: 10.4103/0366-6999.183434.

5.

Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.

Garg M, Kanojia D, Okamoto R, Jain S, Madan V, Chien W, Sampath A, Ding LW, Xuan M, Said JW, Doan NB, Liu LZ, Yang H, Gery S, Braunstein GD, Koeffler HP.

J Clin Endocrinol Metab. 2014 Jan;99(1):E62-72. doi: 10.1210/jc.2013-2994. Epub 2013 Dec 20.

6.

Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.

Hoelting T, Siperstein AE, Clark OH, Duh QY.

J Clin Endocrinol Metab. 1994 Aug;79(2):401-8.

PMID:
8045955
7.

S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma.

Anania MC, Miranda C, Vizioli MG, Mazzoni M, Cleris L, Pagliardini S, Manenti G, Borrello MG, Pierotti MA, Greco A.

J Clin Endocrinol Metab. 2013 Oct;98(10):E1591-600. doi: 10.1210/jc.2013-1652. Epub 2013 Aug 8.

PMID:
23928665
8.

Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence.

Lee I, Park C, Kang WK.

Mol Cancer Ther. 2010 Nov;9(11):2951-9. doi: 10.1158/1535-7163.MCT-10-0511. Epub 2010 Sep 14.

9.

Knockout of Abi3bp in mice does not affect their olfactory function, mental state and NNK-induced lung tumorigenesis.

Yang H, Chen W, Shi J, Huang D, Li J, Hu B, Zhang M, Wang Z, Fei J.

Acta Biochim Biophys Sin (Shanghai). 2016 Sep;48(9):820-6. doi: 10.1093/abbs/gmw071. Epub 2016 Aug 12.

PMID:
27521794
10.

Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.

Nucera C, Nehs MA, Nagarkatti SS, Sadow PM, Mekel M, Fischer AH, Lin PS, Bollag GE, Lawler J, Hodin RA, Parangi S.

Oncologist. 2011;16(3):296-309. doi: 10.1634/theoncologist.2010-0317. Epub 2011 Feb 25.

11.

Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.

Hoffmann S, Maschuw K, Hassan I, Wunderlich A, Lingelbach S, Ramaswamy A, Hofbauer LC, Zielke A.

Endocrine. 2006 Aug;30(1):129-38.

PMID:
17185801
12.

An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.

Iuliano R, Trapasso F, Le Pera I, Schepis F, Samà I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G, Fusco A.

Cancer Res. 2003 Feb 15;63(4):882-6.

13.

The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.

Zwanziger D, Badziong J, Ting S, Moeller LC, Schmid KW, Siebolts U, Wickenhauser C, Dralle H, Fuehrer D.

Endocr Relat Cancer. 2015 Oct;22(5):819-30. doi: 10.1530/ERC-14-0502. Epub 2015 Jul 28.

14.

Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.

Guo G, Kuai D, Cai S, Xue N, Liu Y, Hao J, Fan Y, Jin J, Mao X, Liu B, Zhong C, Zhang X, Yue Y, Liu X, Ma N, Guo Y.

PLoS One. 2013 Apr 17;8(4):e61206. doi: 10.1371/journal.pone.0061206. Print 2013.

15.

BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.

Zheng HC, Li J, Shen DF, Yang XF, Zhao S, Wu YZ, Takano Y, Sun HZ, Su RJ, Luo JS, Gou WF.

Oncotarget. 2015 Aug 14;6(23):19685-705.

16.

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R, Stassi G.

Cancer Res. 2010 Nov 1;70(21):8874-85. doi: 10.1158/0008-5472.CAN-10-1994. Epub 2010 Oct 19.

17.

EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression.

Liu H, Li Z, Li L, Peng H, Zhang Z.

Tumour Biol. 2015 Nov;36(11):8325-31. doi: 10.1007/s13277-015-3523-y. Epub 2015 May 26.

PMID:
26008146
18.

MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1.

Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM, Ma XK, Zhu ZZ, Zhou R.

Biomed Pharmacother. 2016 Oct;83:1-7. doi: 10.1016/j.biopha.2016.05.039. Epub 2016 Jun 15.

PMID:
27470543
19.

The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.

Liu W, Cheng S, Asa SL, Ezzat S.

Cancer Res. 2008 Oct 1;68(19):8104-12. doi: 10.1158/0008-5472.CAN-08-2132.

20.

[Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].

Hoelting T, Duh QY, Clark OH, Herfarth C.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):281-4. German.

PMID:
14518260

Supplemental Content

Support Center